Inhibition of platelet function with clopidogrel is associated with a reduction of inflammation in patients with peripheral artery disease. [electronic resource]
Producer: 20170227Description: 169-75 p. digitalISSN:- 1878-0938
- Anti-Inflammatory Agents -- adverse effects
- Aspirin -- therapeutic use
- Biomarkers -- blood
- Blood Platelets -- drug effects
- CD40 Ligand -- blood
- Chemokine CCL5 -- blood
- Clopidogrel
- Drug Therapy, Combination
- Enzyme-Linked Immunosorbent Assay
- Germany
- Humans
- Inflammation -- blood
- Inflammation Mediators -- blood
- P-Selectin -- blood
- Peripheral Arterial Disease -- blood
- Platelet Activation -- drug effects
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Function Tests
- Tetraspanin 30 -- blood
- Thrombospondins -- blood
- Ticlopidine -- adverse effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.